Company profile: GQ Life Sciences
1.1 - Company Overview
Company description
- Provider of life science information and search solutions: GenomeQuest, a patent search tool for DNA, RNA, and protein sequences with comprehensive comparison algorithms and a large indexed sequence database; and LifeQuest, a life science patent search platform using ontologies to understand biological queries and deliver complete, relevant results without false positives from non-life science patents.
Products and services
- Global Life Science Information and Search Services: Delivers platform-based life science information and search globally, anchored by GenomeQuest and LifeQuest products for life science patent search and biological query understanding
- LifeQuest: An ontology-driven life science patent search platform that uses ontologies to understand biological queries, returning complete, relevant results without false positives from non-life science patents
- GenomeQuest: An algorithmic, sequence-centric patent search tool using DNA, RNA, or protein sequences, with comprehensive sequence comparison algorithms and a large database of indexed sequences.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to GQ Life Sciences
Dotmatics
HQ: United States
Website
- Description: Provider of an enterprise R&D scientific software platform connecting science, data, and decision-making, with applications including electronic laboratory notebook (Dotmatics ELN), Luma AI-native multimodal scientific intelligence, scientific search, small molecule drug discovery solution, and visualization & analytics to streamline research workflows and accelerate innovation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dotmatics company profile →
CLC Bio
HQ: Denmark
Website
- Description: Provider of bioinformatics solutions focused on analyzing data from all major high-throughput sequencing machines, including instruments from Illumina, Applied Biosystems (LIFE Technologies), Roche 454, Helicos, and Sanger.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CLC Bio company profile →
Arxspan
HQ: United States
Website
- Description: Provider of a platform-independent suite of applications with US cloud-based web-delivery for project based research and development collaboration in the pharmaceutical, biotechnology, or chemistry industry, enabling tracking of internal research, management of incoming CRO data, and integration with existing enterprise knowledge management tools via a web-based user interface.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arxspan company profile →
Bina Technologies
HQ: United States
Website
- Description: Provider of a big data science platform delivering scalable genomic analytics for researchers and clinicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bina Technologies company profile →
Genuity Science
HQ: United States
Website
- Description: Provider of clinco-omics data analysis solutions and genomic sequence data for researchers, with a platform for study design, sequencing, storage, interpretation, secondary analysis, and scalable analytics. Offers disease-specific clinical omics datasets (CNS, cardiometabolic, inflammatory), powered datasets, deeply phenotyped whole genomes, longitudinal data, and population-scale expertise applying deep learning to improve patient health using the human genome.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genuity Science company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for GQ Life Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to GQ Life Sciences
2.2 - Growth funds investing in similar companies to GQ Life Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for GQ Life Sciences
4.2 - Public trading comparable groups for GQ Life Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →